clotting factors are produced during the final product of the blood coagulation event of hemostasis.
clotting factors are produced during the final product of the blood coagulation event of hemostasis.
during which event of hemostasis do clotting factors?
final product of the blood coagulation
hemostasis occurs when blood is present outside of the body or blood vessels. it is the innate response for the body to stop bleeding and loss of blood. during hemostasis three steps occur in a rapid sequence. vascular spasm is the first response as the blood vessels constrict to allow less blood to be lost. in the second step, platelet plug formation, platelets stick together to form a temporary seal to cover the break in the vessel wall. the third and last step is called coagulation or blood clotting. coagulation reinforces the platelet plug with fibrin threads that act as a "molecular glue". platelets are a large factor in the hemostatic process. they allow for the creation of the "platelet plug" that forms almost directly after a blood vessel has been ruptured. within seconds of a blood vessel's epithelial wall being disrupted platelets begin to adhere to the sub-endothelium surface. it takes approximately sixty seconds until the first fibrin strands begin to intersperse among the wound. after several minutes the platelet plug is completely formed by fibrin. hemostasis is maintained in the body via three mechanisms:
hemostasis
section::::human blood clotting factors.









































prior to the development and fda approval of a means to produce human blood clotting factors using recombinant dna technologies, human blood clotting factors were produced from donated blood that was inadequately screened for hiv. thus, hiv infection posed a significant danger to patients with hemophilia who received human blood clotting factors: most reports indicate that 60 to 80 percent of patients with hemophilia who were exposed to factor viii concentrates between 1979 and 1984 are seropositive for hiv by [the] western blot assay. as of may 1988, more than 659 patients with hemophilia had aids...
biotechnology in pharmaceutical manufacturing